Beauty
“Scalp serums will not have any effect on areas of the scalp they do not physically touch, so applying them for full scalp coverage is necessary for best results." (Video transcript: "they will not do anything to areas of your scalp that they are not touching... your number one goal should be to get your scalp serum to actually cover as…”
Plain restatementTopical scalp serums act only on the scalp skin they are directly deposited onto, so covering the whole scalp, and depositing on skin rather than hair, is required to obtain the product's benefit.
General information only - not medical or dermatological advice.
A video says scalp serums do nothing to parts of the scalp they do not touch, so you should cover as much scalp as possible. The practical advice is broadly in line with official product instructions. The FDA-approved labels for minoxidil, the main scalp product with regulator-assessed evidence, tell users to apply a set one mL dose directly onto the scalp in the thinning area, and health regulators report that most of an applied dose stays where it is placed. The part that goes too far is the word "any." Published case reports describe hair growing at sites far from where the product was applied, and studies of scalp-applied finasteride show it reaches the bloodstream, so a scalp product is not completely confined to the skin it contacts. The advice also leaves out dose, since spreading the same fixed amount of liquid over more scalp means less per area, and official instructions set a daily maximum. No study was found that compares full-scalp coverage with targeted application, so "necessary for best results" is reasoning from how the drug works rather than something that has been measured, and many cosmetic scalp serums have no established effect to begin with. General information only - not medical or dermatological advice.
Scalp serums [drifted from the evidence:] will not have any effect on [drifted from the evidence:] areas of the scalp [drifted from the evidence:] they do not physically touch, so applying them for full scalp coverage is necessary for best results." (Video transcript: "they will not do anything to areas of your scalp that they are [drifted from the evidence:] not touching... your number one goal should be to get your scalp serum to actually cover as much of your scalp as possible... make sure that the serum is actually depositing directly onto [drifted from the evidence:] your scalp and [drifted from the evidence:] not just on [drifted from the evidence:] top of your hair, [drifted from the evidence:] or it's not going to [drifted from the evidence:] work.")
[added by the neutral restatement:] Topical scalp serums [added by the neutral restatement:] act only on the scalp [added by the neutral restatement:] skin they are directly [added by the neutral restatement:] deposited onto, [added by the neutral restatement:] so covering the whole scalp, and [added by the neutral restatement:] depositing on [added by the neutral restatement:] skin rather than hair, [added by the neutral restatement:] is required to [added by the neutral restatement:] obtain the product's benefit.
Red-tinted words in the claim drifted from the evidence. Green-tinted words are what a neutral restatement needs.
The trace / claim to source
- The product has to reach scalp skin. FDA Drug Facts labels for 2% and 5% minoxidil topical solution direct users to apply one mL with the dropper twice daily directly onto the scalp in the hair loss area, which matches the video's point about depositing on scalp rather than on hair.
- Most of a topical minoxidil dose stays where it is put. Health Canada's monograph gives average absorption of about 1.4% of the applied dose, range 0.3 to 4.5%, from normal intact scalp, and a 2024 review states most of the applied dose remains localised at the application site.
- Parting the hair to expose scalp lines is consistent with how the labelled products direct application, and no source contradicts the idea that untreated areas receive little drug.
- The claim says the serum will have no effect at all on scalp it does not touch. Published case reports describe hair growth at distant sites after topical minoxidil use, including generalised hypertrichosis and a case linked to systemic absorption under scalp occlusion, and topical finasteride studies show scalp application lowers serum DHT as well as scalp DHT. These are small and often unwanted effects rather than useful regrowth where you want it, but they show the absolute wording is not supported.
- "Cover as much of your scalp as possible" omits the dose. The FDA labels pair a fixed one mL dose with a defined treatment area, and no more than 2 mL in 24 hours. Spreading the same fixed volume over a larger area delivers less per unit area, so coverage and dose cannot be treated as independent.
- "Scalp serums" is treated as one thing. Minoxidil is an OTC drug with registration trial evidence; most cosmetic scalp serums are not, and advice on how to apply them presupposes an effect that has not been established for each product.
- "Necessary for best results" is stated as settled. I found no trial comparing full-scalp coverage with targeted application on shedding or density, so this is a mechanistic inference, not a measured finding.
- Whether full-scalp coverage outperforms targeted application for shedding or density. No comparative study was located.
- How far applied liquid actually spreads laterally across scalp skin and through the sebum film and follicular openings between parted sections. The relevant half-scalp trial could not be read in primary form.
- Whether product that lands on hair shafts rather than skin is entirely wasted, or partly redistributed to the scalp during massage. No study located either way.
- Whether cosmetic, non-drug scalp serums produce a measurable effect at all, which the application advice assumes.
The only scalp-applied products with regulator-assessed efficacy are drugs, chiefly topical minoxidil. The FDA Drug Facts labels for 2% and 5% minoxidil topical solution instruct users to apply one mL with the dropper twice daily directly onto the scalp in the hair loss area, and Medscape's FDA-derived monograph states a ceiling of 2 mL in 24 hours. That is a fixed dose directed at the thinning area, not an instruction to cover the entire scalp. On how far the drug travels, Health Canada's product monograph states that absorption of topical minoxidil from normal intact scalp averages about 1.4%, range 0.3 to 4.5% of the applied dose, and that occlusion increases absorption. A 2024 peer-reviewed review states that minoxidil shows limited systemic absorption and that most of the applied dose remains localised at the site of application. So the dominant behaviour of the drug is local. However, "local" is not "zero elsewhere." Published case reports describe hair growth at sites far from where the product was applied, including generalised hypertrichosis attributed to topical minoxidil and a case attributed to systemic absorption under scalp occlusion. DermNet notes unwanted hair growth can occur, for example if solution drips onto the forehead. Separately, topical finasteride studies show scalp-applied drug lowers serum DHT as well as scalp DHT, although less than oral dosing, demonstrating that a scalp-applied active can act beyond the skin it contacts. Low-dose oral minoxidil also regrows hair systemically, which shows the follicle does not need surface contact to respond, only sufficient delivery. I found no study comparing full-scalp coverage against partial or targeted application for shedding or density outcomes, and no study testing whether product left on hair shafts rather than scalp skin changes outcomes.
Complete reasoning
The reply is formatted for pasting into the thread where the claim is circulating.